Neogen Chemicals Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Haridas Kanani
Chief executive officer
₹12.7m
Total compensation
CEO salary percentage | 99.6% |
CEO tenure | 35.8yrs |
CEO ownership | 43.6% |
Management average tenure | 3.2yrs |
Board average tenure | 7yrs |
Recent management updates
Recent updates
Here's Why Neogen Chemicals (NSE:NEOGEN) Has A Meaningful Debt Burden
Dec 26The Returns On Capital At Neogen Chemicals (NSE:NEOGEN) Don't Inspire Confidence
Dec 10Why Neogen Chemicals' (NSE:NEOGEN) Shaky Earnings Are Just The Beginning Of Its Problems
Nov 20Earnings Miss: Neogen Chemicals Limited Missed EPS By 6.7% And Analysts Are Revising Their Forecasts
Nov 16Investors Appear Satisfied With Neogen Chemicals Limited's (NSE:NEOGEN) Prospects As Shares Rocket 36%
Sep 20We Think That There Are More Issues For Neogen Chemicals (NSE:NEOGEN) Than Just Sluggish Earnings
May 08Earnings Miss: Neogen Chemicals Limited Missed EPS By 24% And Analysts Are Revising Their Forecasts
May 05After Leaping 27% Neogen Chemicals Limited (NSE:NEOGEN) Shares Are Not Flying Under The Radar
Apr 26Are Neogen Chemicals Limited (NSE:NEOGEN) Investors Paying Above The Intrinsic Value?
Apr 12Neogen Chemicals (NSE:NEOGEN) Is Increasing Its Dividend To ₹2.75
Aug 11Neogen Chemicals Limited (NSE:NEOGEN) Just Reported Earnings, And Analysts Cut Their Target Price
Aug 10Here's Why I Think Neogen Chemicals (NSE:NEOGEN) Is An Interesting Stock
Feb 09Neogen Chemicals' (NSE:NEOGEN) Returns On Capital Not Reflecting Well On The Business
Sep 21Neogen Chemicals' (NSE:NEOGEN) Dividend Will Be Increased To ₹2.25
Sep 05Neogen Chemicals (NSE:NEOGEN) Will Pay A Larger Dividend Than Last Year At ₹2.25
Aug 11Does Neogen Chemicals (NSE:NEOGEN) Deserve A Spot On Your Watchlist?
Jun 04Should You Think About Buying Neogen Chemicals Limited (NSE:NEOGEN) Now?
May 24Neogen Chemicals (NSE:NEOGEN) May Have Issues Allocating Its Capital
Apr 05Is Neogen Chemicals Limited's(NSE:NEOGEN) Recent Stock Performance Tethered To Its Strong Fundamentals?
Mar 07Should You Buy Neogen Chemicals Limited (NSE:NEOGEN) For Its Dividend?
Feb 21Does Neogen Chemicals (NSE:NEOGEN) Have A Healthy Balance Sheet?
Jan 26Could The Neogen Chemicals Limited (NSE:NEOGEN) Ownership Structure Tell Us Something Useful?
Jan 13The Returns At Neogen Chemicals (NSE:NEOGEN) Provide Us With Signs Of What's To Come
Dec 31Don't Ignore The Fact That This Insider Just Sold Some Shares In Neogen Chemicals Limited (NSE:NEOGEN)
Dec 18CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | ₹404m |
Jun 30 2024 | n/a | n/a | ₹374m |
Mar 31 2024 | ₹13m | ₹13m | ₹357m |
Dec 31 2023 | n/a | n/a | ₹330m |
Sep 30 2023 | n/a | n/a | ₹467m |
Jun 30 2023 | n/a | n/a | ₹486m |
Mar 31 2023 | ₹8m | ₹8m | ₹500m |
Dec 31 2022 | n/a | n/a | ₹513m |
Sep 30 2022 | n/a | n/a | ₹471m |
Jun 30 2022 | n/a | n/a | ₹484m |
Mar 31 2022 | ₹6m | ₹6m | ₹446m |
Dec 31 2021 | n/a | n/a | ₹383m |
Sep 30 2021 | n/a | n/a | ₹364m |
Jun 30 2021 | n/a | n/a | ₹326m |
Mar 31 2021 | ₹6m | ₹6m | ₹313m |
Dec 31 2020 | n/a | n/a | ₹293m |
Sep 30 2020 | n/a | n/a | ₹290m |
Jun 30 2020 | n/a | n/a | ₹293m |
Mar 31 2020 | ₹5m | ₹5m | ₹287m |
Dec 31 2019 | n/a | n/a | ₹301m |
Sep 30 2019 | n/a | n/a | ₹262m |
Jun 30 2019 | n/a | n/a | ₹225m |
Mar 31 2019 | ₹5m | ₹5m | ₹209m |
Mar 31 2018 | ₹3m | ₹3m | ₹110m |
Compensation vs Market: Haridas's total compensation ($USD147.30K) is below average for companies of similar size in the Indian market ($USD351.12K).
Compensation vs Earnings: Haridas's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
CEO
Haridas Kanani (78 yo)
35.8yrs
Tenure
₹12,650,000
Compensation
Mr. Haridas Thakarshi Kanani, B.Tech (Chem), M.I.I.Ch.E. serves as the Chairman and Managing Director of Neogen Chemicals Limited and serves as its Director since March 07, 1989. He oversees the manufactur...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman & MD | no data | ₹12.65m | 43.63% ₹ 24.6b | |
MD & Executive Director | 7.5yrs | ₹19.85m | 7.59% ₹ 4.3b | |
Director of Operations & Whole Time Director | no data | ₹9.15m | no data | |
Chief Financial Officer | less than a year | no data | no data | |
Company Secretary & Compliance Officer | 5.2yrs | ₹690.56k | no data | |
Senior General Manager of Marketing | no data | no data | no data | |
Senior Vice President of Human Resource | no data | no data | no data | |
Senior Vice President of Business Development | 1.3yrs | no data | no data |
3.2yrs
Average Tenure
71yo
Average Age
Experienced Management: NEOGEN's management team is considered experienced (3.2 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman & MD | 35.8yrs | ₹12.65m | 43.63% ₹ 24.6b | |
MD & Executive Director | 11.5yrs | ₹19.85m | 7.59% ₹ 4.3b | |
Director of Operations & Whole Time Director | 9.5yrs | ₹9.15m | no data | |
Non Executive & Non-Independent Director | 7.7yrs | no data | no data | |
Independent Non-Executive Director | 6.3yrs | ₹300.00k | no data | |
Independent Non-Executive Woman Director | 6.3yrs | ₹500.00k | no data | |
Additional Non-Executive Independent Director | less than a year | no data | no data | |
Independent Director | less than a year | no data | no data |
7.0yrs
Average Tenure
65yo
Average Age
Experienced Board: NEOGEN's board of directors are considered experienced (7 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/08 09:22 |
End of Day Share Price | 2025/01/08 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Neogen Chemicals Limited is covered by 19 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Nav Bhardwaj | Anand Rathi Shares and Stock Brokers Limited |
Bhawana Israni | Anand Rathi Shares and Stock Brokers Limited |
null null | Anand Rathi Shares and Stock Brokers Limited |